Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Academic investigators report potential anti-HIV agents

May 10, 1996

FR-133605 effective in preclinical models of rheumatoid arthritis, septic shock

May 3, 1996

F-792: Truncated oxytocin analogue from Ferring

May 3, 1996

Fujisawa synthesizes novel beta3-agonist

May 3, 1996

PS-028: Fibrinogen antagonist from Taisho

May 3, 1996

Fuji Pharm. reports new antiplatelet agent

May 3, 1996

Novel PAI-1 inhibitor protects against vascular lesions

May 3, 1996

Ajinomoto reports on antihypertensive agent AP-1067

May 3, 1996

TAK-218 discussed at length at Japanese meetings

May 3, 1996

Tanabe's T-477 shows neuroprotective effects

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.